AbbVie Inc. (ABBV) vs Eli Lilly and Company (LLY)
LLY leads on 10 of 15 compared metrics.
A side-by-side comparison of AbbVie Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABBV vs LLY
growth of $100 · last 14yABBV +544.8%LLY +2139.1%LLY compounded faster
ABBV LLY
ABBV vs LLY: by the numbers
- •LLY is the larger company ($1.07T vs $402.35B market cap).
- •LLY trades at the lower earnings multiple (40.25 vs 111.67 P/E).
- •LLY converts more revenue to profit (34.98% vs 5.79% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 4.59% CAGR).
- •ABBV pays the higher dividend yield (2.96% vs 0.57%).
Which is better, ABBV or LLY?
Metric tally: ABBV 5 · LLY 10It depends on what you're optimizing for:
ValueLLY(lower P/E)
GrowthLLY(faster 5Y revenue CAGR)
IncomeABBV(higher dividend yield)
QualityLLY(higher ROIC)
Valuation
| Metric | ABBV | LLY |
|---|---|---|
| P/E ratio | 111.67 | 40.25● |
| Forward P/E | — | 25.41 |
| P/S ratio | 6.43● | 14.05 |
| P/B ratio | 14.69● | 32.54 |
| PEG ratio | — | 0.49 |
| EV / EBITDA | 27.63● | 31.47 |
| FCF yield | 5.17%● | 1.34% |
Profitability
| Metric | ABBV | LLY |
|---|---|---|
| Gross margin | 70.68% | 83.51%● |
| Operating margin | 27.60% | 45.87%● |
| Net margin | 5.79% | 34.98%● |
| ROE | 13.23% | 81.01%● |
| ROIC | 12.97% | 30.20%● |
Dividends
| Metric | ABBV | LLY |
|---|---|---|
| Dividend yield | 2.96%● | 0.57% |
| Payout ratio | 284.39% | 28.09% |
Growth (annualized)
| Metric | ABBV | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 23.17%● |
| EPS CAGR (5Y) | -2.79% | 28.88%● |
| FCF CAGR (5Y) | 3.24% | 19.54%● |
| Total return CAGR (5Y) | 18.95% | 39.57%● |
Frequently asked
- Which is better, ABBV or LLY?
- It depends on your goal. value: LLY (lower P/E); growth: LLY (faster 5Y revenue CAGR); income: ABBV (higher dividend yield); quality: LLY (higher ROIC). Across all compared metrics, LLY leads 10 to 5.
- Is ABBV or LLY cheaper?
- On trailing earnings, LLY is cheaper: ABBV trades at a 111.67 P/E and LLY at 40.25.
- Which has grown faster, ABBV or LLY?
- Over the past five years, LLY grew revenue faster — ABBV at a 4.59% CAGR versus LLY at 23.17%.
- Does ABBV or LLY pay a bigger dividend?
- ABBV yields 2.96% and LLY yields 0.57% based on trailing dividends and the latest price.
- Is ABBV or LLY more profitable?
- LLY runs the higher net margin — ABBV at 5.79% versus LLY at 34.98%.
- Which has been the better investment, ABBV or LLY?
- Over the past 10-year, LLY delivered the higher annualized total return — ABBV at 18.88% versus LLY at 33.50%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioEli Lilly and P/E ratioAbbVie dividend yieldEli Lilly and dividend yieldAbbVie ROEEli Lilly and ROEAbbVie operating marginEli Lilly and operating marginAbbVie revenue growthEli Lilly and revenue growthAbbVie free cash flowEli Lilly and free cash flow
AbbVie & Eli Lilly and appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.